
Guadalupe
Hayes-Mota
Biotech & AI Expert
Business Leader
Public Servant
Global Impact in Numbers
At-a-Glance




About
Guadalupe Hayes-Mota directs the Bioethics Program at Santa Clara University and lectures at MIT, championing responsible innovation where healthcare, technology, and ethics meet. Drawing on two decades of supply-chain leadership and entrepreneurial success, he now deploys AI platforms that make lifesaving therapies reachable for patients everywhere.
​
-
Role: Director of the Bioethics Program at Santa Clara University and Senior Lecturer in biotech & AI ethics at MIT
-
Scale of impact: Orchestrated AI-powered supply chains that delivered medicines to 2.3 billion+ patients in 113 countries, while advising Fortune 500 boards and federal agencies
-
Research focus: Generative AI, natural-language processing, and predictive analytics that shorten drug-development timelines and expand global access to treatment
Born in rural Mexico with severe hemophilia, Guadalupe nearly died at 12 when an appendix rupture sent him bleeding out on the operating table—only to be revived after an eight-hour ambulance ride. His family then immigrated to California with little money or English, driving hours for every specialist visit and relying on a local Hemophilia Association for lifesaving care. This early brush with death and firsthand experience of healthcare inequity ignited his lifelong mission to make quality care accessible to all.
Origin
Story

Video: Guadalupe speaks about growing up with hemophilia in Mexico without medicines.
Leadership

-
CEO & Co-Founder – Stealth-Mode AI Healthcare Startup
Developed next-gen AI platforms expanding global access to lifesaving treatments. -
Director, Bioethics & Applied Ethics Instructor – Santa Clara University
Designed ethics curriculum and advanced research in AI, biotech, and health-policy innovation. -
Founder & CEO – Healr Solutions
Scaled an AI-powered biopharma supply-chain platform to 43 countries; led successful acquisition. -
Senior Lecturer – Massachusetts Institute of Technology
Led courses in biotech operations, supply-chain strategy, and emerging-technology ethics. -
SVP & Chief Supply Chain Officer – Ultragenyx, Biogen, Amgen & GSK
Directed global supply chains delivering medicines to 2.3 billion people in 113 countries. -
Executive Director of Ambulatory Clinics – UCLA Health
Expanded free-care network to 30 000 underserved patients, making UCLA the nation’s largest free provider. -
Health Policy Analyst – RAND Corporation
Shaped Affordable Care Act analysis at RAND, extending coverage to 20 million Americans. -
Research Associate – MIT Langer Lab
Advanced drug-delivery research that informed Moderna’s mRNA platform.
BOARDS & ADVISORY COUNCILS
Government & Multilateral Appointments
-
Member, NIH Cures Acceleration Network Review Board (appointed by President Biden)
-
Member, Massachusetts Rare Disease Advisory Council (appointed by Governor Baker)
-
AI Expert Advisor, European Commission
-
AI Expert Advisor, World Economic Forum
​​
Corporate & Nonprofit Boards
-
Advisory Board Member, Sanofi
-
Board Member, Blue Clay Health
-
Board Member, Fenway Health
-
Board Member, Save One Life
-
Board Member, MIT Alumni Association
​​
Industry Advisory Councils
-
Advisory Council Member, AI 2030
-
AI & Biotech Expert Advisor, OpenAI
-
Advisory Council Member, Forbes Business Council
-
Advisory Council Member, Fast Company Impact Council
-
Advisory Council Member, Harvard Business Review Advisory Council

THOUGHT LEADERSHIP

Media Features
-
Featured in Forbes
-
Featured in Inc.
-
Featured in Fast Company
-
Featured in MarketWatch
-
Featured in Boston Globe
-
Featured in MIT Technology Review
Keynotes & Testimony
-
Keynote speaker, National Academy of Engineering
-
Keynote speaker, MIT
-
Keynote speaker, Harvard University
-
Keynote speaker, University of Pennsylvania
-
Testified before the U.S. Congress on critical healthcare issues
Writing & Contributions
-
Regular contributor, Forbes (biotechnology, AI, business innovation)
-
Regular contributor, Fast Company (biotechnology, AI, business innovation)
EDUCATION
.png)
-
BS in Chemistry & BS in Literature – MIT
-
MS in AI Engineering Systems – MIT
-
MBA – MIT
-
Master of Public Administration – Harvard University
-
Doctor of Engineering in AI – George Washington University
HONORS
-
6 Powerful LGBTQ+ Executives - Business Insider
-
US Young Engineering Leader - National Academy of Engineering
-
John F. Kennedy Fellowship - Harvard University
-
Notable Alum - MIT
-
100 Top Leaders in the Life Science Industry - PharmaVoice
-
40 under 40 - Boston Business Journal
-
Healthcare Executive of the Year - Los Angeles Business Journal
Public Service

NIH
Cures Acceleration Network
Board Member
Appointed by the U.S President and U.S. Health and Human Services Secretary to advise the NIH, federal agencies, and stakeholders on advancing and accelerating the development of high-need cures.
Rare Disease Advisory Council
Council Member
Appointed by Governor Baker to provide advice to the Governor, Senate, House of Representatives, and Department of Public Health on how to address rare disease policy and actions in Massachusetts.

European Commission
AI Expert Advisor
Provided guidance to the Commission, EU member states, and stakeholders on fostering the development and adoption of trustworthy AI technologies across Europe.

World Economic Forum
AI Expert Advisor
​
Advises on the integration of AI in healthcare, public policy, and business, contributing to global discussions on responsible AI deployment.
Teaching
​
Teacher/ Mentor of the Next Generation of STEM Entrepreneurs Leaders


Keynote Speaker (Harvard Center for Public Leadership): Guadalupe talks about how curiosity saved his life by developing new drugs
Keynote Presentation (Clinical Trials Summit): Guadalupe talks about how to manage Clinical Global Supply Chains during COVID-19 times.
Speaking Engagements

Keynote Speaker (National Academy of Engineering): Guadalupe explores the technology needed to create connected supply chain in the biopharmaceutical world.

Keynote Speaker (Pharmaceutical Industry Association of Puerto Rico): Guadalupe discusses how to create access to medicines to patients worldwide

Presentation (Biomanufacturing and Cell and Gene Therapy Strategy Meeting): Guadalupe presents about Internet of Things (IIoT) insights and knowledge to minimize waste within manufacturing systems.
